India to Philippines: Heparin Export Trade Route

The India to Philippines Heparin corridor is one of India's established pharmaceutical export routes, with 206 shipments documented worth a combined $14.4M USD. The route is dominated by SAKAR HEALTHCARE LIMITED, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's heparin manufacturing sector.

Across 19 active suppliers, the average shipment value stands at $70.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 26.7%, placing it at rank #17 among India's top heparin export destinations globally.

On the import side, key buyers of Indian heparin in Philippines include NA, TO THE ORDER OF SECURITY BANK CORPO, TO THE ORDER OF ASIA UNITED BANK CO and 38 others. NA is the single largest importer with 36 shipments valued at $3.8M USD.

India's heparin exports to Philippines are driven primarily by a handful of large-scale manufacturers. SAKAR HEALTHCARE LIMITED with 62 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SAKAR HEALTHCARE LIMITED, SAKAR HEALTHCARE LIMITED , TROIKAA PHARMACEUTICALS LIMITED — together account for 71% of total trade value on this route. The average shipment value of $70.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as heparin injection bp (5000 iu/ml) sakarin 25000 and heparin injection bp (1000 iu/ml) sakarin 5000, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 36 shipments worth $3.8M USD — representing 26% of all heparin imports from India on this route. A total of 41 buyers are active on this corridor.